Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
0.7199
+0.0324 (4.71%)
At close: Apr 23, 2025, 4:00 PM
0.7150
-0.0049 (-0.68%)
After-hours: Apr 23, 2025, 5:01 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $209.37 million as of April 23, 2025. Its market cap has decreased by -55.40% in one year.
Market Cap
209.37M
Enterprise Value
183.36M
1-Year Change
-55.40%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since December 3, 2014, Ocugen's market cap has increased from $126.80M to $209.37M, an increase of 65.12%. That is a compound annual growth rate of 4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 200.90M | -14.33% |
| Dec 31, 2024 | 234.50M | 58.98% |
| Dec 29, 2023 | 147.50M | -48.17% |
| Dec 30, 2022 | 284.60M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.67% |
| Dec 31, 2020 | 296.50M | 3,472.29% |
| Dec 31, 2019 | 8.30M | 50.91% |
| Dec 31, 2018 | 5.50M | -88.84% |
| Dec 29, 2017 | 49.30M | 85.34% |
| Dec 30, 2016 | 26.60M | -42.80% |
| Dec 31, 2015 | 46.50M | -60.86% |
| Dec 31, 2014 | 118.80M | -6.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 744.65B |
| UnitedHealth Group | 389.54B |
| Johnson & Johnson | 374.10B |
| AbbVie | 313.02B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.15B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |